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ABSTRACT

Modifiable and non-modifiable factors associated with DKA among children and adolescents
with Type 1 diabetes: A machine learning exploration using the T1D Exchange data set
By
Bridget Bassett
Dec 8, 2022
INTRODUCTION: Diabetic ketoacidosis (DKA) is a serious life-threatening complication among
pediatric patients with Type 1 diabetes. Even one instance of DKA can predispose a patient to
more episodes of DKA in the future compounding the complications and risks.
AIM: The aim of this study is to use LASSO, a new variable selection method, to determine
novel risk factors for DKA.
METHODS: The T1D Exchange dataset was used for a new variable selection technique for
diabetic ketoacidosis (DKA) among pediatric patients in the United States. With DKA as a binary
outcome, the HPGENSELECT procedure was used while LASSO or L1 regression was employed
to create sparse models for variable selection.
RESULTS: The following modifiable variables were selected: number of blood glucose checks
per patient per day, BMI, albumin creatinine ratio, systolic and diastolic blood pressure, BUN
levels, having a hypoglycemic event in the previous three months and lipid levels
(HDL/LDL/total cholesterol/triglycerides). The non-modifiable variables that were selected in
the model are the following: age, diabetes duration in years, height and months from exam
date. The model did produce an acceptable AUC for predictive ability.
DISCUSSION: The problem of finding modifiable risk factors for pediatric patients continues to
be challenging, even if it is vitally important. The data in this study were both collected
retrospectively and voluntarily, and their use for a predictive model should be used with
caution. Machine learning techniques offer the potential to identify novel risk factors for DKA
among pediatric patients if EHR are used and the dataset is large enough.
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INTRODUCTION
Type 1 Diabetes (T1D) is an autoimmune disease characterized by progressive loss of pancreatic
beta cells resulting in insulin deficiency and high blood sugar. This high blood sugar is called
hyperglycemia. Prior to 1921, patients diagnosed with Type 1 diabetes were given no hope of
long-term survival. The discovery of artificial insulin was one of the greatest breakthroughs in
medical history (Rosenfeld, 2002). Since the invention of insulin, there have been continuous
improvements in diabetes care and technology enabling better quality of life and long-term
outcomes. These breakthroughs include continuous glucose monitors, subcutaneous insulin
pumps and the hormone glucagon for hypoglycemic emergencies (Lauritzen et al., 1979). A
healthy life is now possible with these advancements for individuals with Type 1 diabetes.

Despite these advances, few adult or pediatric patients maintain optimal levels of blood
glucose. The gold standard for measuring an average blood glucose over the previous three
months is the HbA1c value. Current guidelines suggest an endocrinology visit every three
months for all persons with Type 1 diabetes that includes an HbA1c test. The vast majority of
pediatric patients do not maintain an HbA1c value less than the value recommended by the
American Diabetes Association and the International Society of Pediatric and Adolescent
Diabetes of 7.5% (Chiang et al., 2014). Only 17% of patients under the age of 18 have an A1C
below 7.5% (Foster et al., 2019).
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There are widely known short- and long-term complications of poorly managed Type 1
diabetes in the medical literature. Long term complications are usually the result of years of
mild to moderate hyperglycemia and are considered microvascular complications. These
microvascular complications target organ systems that place a high demand on
microvasculature such as the eyes, kidneys and nerves of the extremities (Nathan, 2014). The
findings from the Diabetes Control and Complication Trial (DCCT) show that patients could slow
the development of eye, kidney and nerve disease with intensive diabetes treatment. This type
of intensive diabetes treatment is difficult to manage and maintain over a long period of time.

The two most widely known acute complications of Type 1 diabetes are extreme hypoglycemia
and diabetic ketoacidosis (DKA). They are emergencies and are fatal if not treated quickly. Both
complications are widely considered preventable. The aim of this current study uses a novel
variable selection technique using machine learning and LASSO regression for DKA occurrence
in pediatric patients. Using a large dataset from the T1D Exchange Registry, we hope to
determine modifiable and non-modifiable risk factors for pediatric and adolescent patients to
improve the body of evidence for future studies.

What is DKA?
Diabetes ketoacidosis is a complication of severe insulin deficiency. This insulin deficiency leads
to hyperglycemia, dehydration and ketogenesis leading to acidosis, coma, and death if
untreated. DKA can occur at diagnosis or anytime during the life of a person with Type 1 as
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Type 1 is a chronic autoimmune illness. DKA occurs because of inappropriate management of
blood sugar levels or accidental or intentional omission of insulin.

Current known risk factors for DKA include omission of insulin, limited access to medical
services and unrecognized interruption of insulin delivery in patients using an insulin pump
(Wolfsdorf et al., 2018). A population-based cohort study in Switzerland over 10 years showed
that the risk was highest at around 15 years of age for DKA. The risk was most pronounced
during adolescence and for girls.

Not maintaining optimal glycemic control has been shown to be a major risk factor for DKA in
pediatric patients. Worsening glycemic control in puberty is common. Poor glycemic control
during adolescence has been shown to be caused by poor diabetes acceptance, psychiatric
disorders (depression, anxiety, eating disorders) and risk-taking behavior that is seen in
adolescent development (Ebrahimi et al., 2022). Risk for DKA is also increased in children who
omit insulin, children with poor metabolic control or previous episodes of DKA, gastroenteritis
with persistent vomiting and inability to maintain hydration, children with psychiatric disorders,
including eating disorders, children with difficult or unstable family circumstances, peripubertal
and adolescent girls, binge alcohol consumption and children with limited access to medical
services (Raghupathy, 2015).

DKA and especially recurrent DKA can cause permanent cognitive deficits in all patients but
particularly in pediatric patients. The desire for autonomy during adolescence, refusing parental
9

support for diabetes management and peer acceptance can also play a behavioral role in the
care of diabetes management for teenagers. The risk for DKA in established Type 1 diabetes
patients is 1 to 10% per patient per year (Wolfsdorf et al., 2018).

Recurrent DKA is associated with older age (in relation to pediatric patients or the early teenage
years), higher HbA1c levels and higher insulin doses. DKA was found to be most frequent in
adolescents and associated with higher HbA1c values, nonwhite race, lack of private health
insurance and lower household income (Jefferies et al., 2015).

Children and teens who have Type 1 diabetes have an increased mortality compared to the
general population and DKA is the leading cause of death for pediatric patients with Type 1
particularly if it is complicated by cerebral edema (Edge et al., 1999). Even one occurrence of
moderate to severe DKA in young children has been found to be associated with lower
cognitive scores and altered brain growth. Cerebral edema because of DKA in the study by
Edge, et al. is one of the common causes of death among children under 20. The incidence of
ketoacidosis was 8 per 100 person-years and increased with age in girls, with some
stratification among age for factors associated with it in a study among a cohort of 1243
children in Denver over 19 years (Rewers et al., 2007).

Since the basic treatment of DKA involves insulin administration and the correction of fluid and
electrolyte imbalances, most patients are managed in a hospital intensive care unit to be
monitored closely. For this reason, DKA treatment in the United States has an average annual
10

cost of more than $5 billion dollars (National Diabetes Statistics Report 2020. Estimates of
Diabetes and Its Burden in the United States., 2020). Resource use for treating DKA among
pediatric patients is yet another reason why more information is needed to determine new risk
factors for DKA. Eighty percent of DKA episodes occurred among 20% of those children with
recurrent events. In 2014, the DKA hospitalization rate among persons with diabetes aged less
than 45 was approximately 27 times the rate among persons older than 65 years old (Benoit et
al., 2018).

Modifiable versus Nonmodifiable Risk Factors
Most of the research on the incidence of DKA for pediatric patients and the risk factors that
have been determined are not modifiable by pediatric or adolescent patients as they are
dependent on factors outside of their control. Family income, race/ethnicity and insurance type
are some examples of non-modifiable risk factors. BMI and HbA1c are modifiable with proper
continued education or family support. Other biomarkers such as blood pressure, lipid levels
and measures of kidney health such as BUN level are also modifiable. Our study aims to use
machine learning to help distinguish between these modifiable and non-modifiable risk factors.

There are many documented options to provide education and support to patients and family
members including a care coordination approach. There are also several different diabetes
education methods to help address HbA1c levels, BMI, correct insulin dosage and sick day
management. There is some evidence on cognitive -behavioral interventions and family
systems approaches as options to address modifiable risk factors (Wagner et al., 2015).
11

The extended health belief model can help explain the socio-psychological factors at play for
pediatric and adolescents with Type 1 diabetes. The extended health belief model describes
both coping mechanisms and self-management behaviors that are critically related to overall
health (Harvey & Lawson, 2009). The Gillibrand, et al (2006) study found that those young
adult patients with the highest family support had the highest scores in self-care of diabetes.
This indicates the need to support the whole family in diabetes education (Gillibrand &
Stevenson, 2006).

Not only are a high percentage of pediatric patients with Type 1 living with higher than optimal
HbA1c levels, but more young people are also being diagnosed with the disease every year. The
global incidence of Type 1 is increasing 3% per year in children and adolescents and 5% per year
in preschoolers (Patterson et al., 2014).

REVIEW OF THE LITERATURE
Machine learning is an inherently different method for data analysis. Risk prediction models
prior to using machine learning were based on a literature review and clinical knowledge of the
disease or diagnosis to inform the model. This method builds a model with variables that are
based on current knowledge. Machine learning allows researchers to look for new explanatory
variables that might help explain some new or unknown effects or variables. The effort in this
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study has been to use a new method for variable selection for a desired outcome. It is an
exploration of machine learning.

Variable selection is an important step in any analysis. Variable selection methods include
filter, wrapper and embedded methods. Filter methods allow the user to filter out the data for
feature selection based on general characteristics of the data. Filtering methods require the
user to determine a cut-off value or threshold for variable inclusion. These can include F-ratios,
selectivity ratios and VIP scores. Wrapper methods evaluate subsets through iterations of the
algorithm and return the best performing subset. This includes forward and backward selection.
Embedded methods include forms of regularization, such as L1 or LASSO as we have done in
this analysis (Kavakiotis et al., 2017; Sorochan Armstrong et al., 2022).

There are many examples of employing the wrapper method for DKA detection. Abakar, et al.
used a tree-based classifier as a method for reducing the number of features in their DKA
prediction model. They divided their features into categories and used a random forest
algorithm to reduce the number of features from 28 to 5 (Abaker & Saeed, 2020).

Fralick, et al. used two different machine learning algorithms for classification and for feature
selection. Gradient boosted trees defined predictors for DKA as having had a previous DKA,
baseline HbA1c, baseline creatinine level, use of medications for dementia and baseline
bicarbonate level. They used LASSO regression and found that prior DKA, digoxin use, use of
medications for dementia and recent hypoglycemia were predictors for DKA (Fralick et al.,
13

2021). This analysis used a combination of the predictors they found and then assessed them in
a logistic regression.

Fan, et al. used LASSO regression to identify candidate predictors for predicting acute kidney
failure among patients in intensive care units for DKA. The Medical Information Mart for
Intensive Care III database was used for this study. A multivariate logistic regression was done
using the predictors discovered from the LASSO regression. A nomogram or a graphical
representation as a function of several variables was constructed for the outcome of acute
kidney disease (Fan et al., 2021).

In a study on cerebral oedema as a complication diabetic ketoacidosis in children, researchers
used stepwise variable selection for their logistic regression model. Their study used
biochemical variables at hospital admission and treatment variables while hospitalized. This
study proved that treatment decisions while in the hospital played a role in whether patients
developed cerebral edema while in DKA. Although the outcome is slightly different for this
study, the aims and methods used highlight how important the variable selection method is
when doing any type of analysis (Edge et al., 2006).

A similar study evaluating predictors of dehydration in children with DKA used forward stepwise
logistic regression to identify clinical and biometric predictors for severe dehydration(Trainor et
al., 2021) While both Trainor, et al. and Edge, et al. did not use a machine learning algorithm for
variable selection they both illustrate the use of a filter variable selection.
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Outside of variable selection, machine learning algorithms are currently used in academic
research to improve the lives for those living with diabetes. Published research has included the
use of machine learning to forecast future blood glucose levels in adults with Type 1 (De Paoli
et al., 2021). In a viewpoint article in the JAMA in 2018, Beam et al, compared several methods
of machine learning, deep learning, risk calculators, results from randomized clinical trials
among others comparing the various methods and noting the benefits of machine learning
(Beam & Kohane, 2018). This provided a valuable resource to objectively compare the methods
and results of these most common ways to analyze data. Another work by Vehi, et al. in 2020
developed multiple methods of machine learning to prevent and predict hypoglycemic events
for adults with Type 1. This study used four different machine learning methods that might
enhance tight glycemic control without severe hypoglycemic events (Vehí et al., 2020).

A seminal work in the use of machine learning for DKA prediction was done by Lin, et al. Their
study used six different types of flexible machine learning (XGBoost, distributed Random Forest
and feedforward network) along with conventional machine learning (logistic regression and
LASSO). They gathered 3400 DKA cases from adults in the Optum de-identified electronic health
record system. The models they created using machine learning demonstrated similar
performance and identified “overlapping, but different” top 10 predictors for adults with Type 1
diabetes developing DKA (Li et al., 2021). Unfortunately, their study did not include pediatric
patients for DKA prediction but did show a unique set of different machine learning options
that all produced overlapping, but different predictors for DKA.
15

Conversely, Schwartz, et al. created a simple risk prediction model for DKA from variables
derived from EHR data for pediatric patients. They developed an automatic risk index using the
variables of previous DKA, most recent HbA1c and type of insurance coverage. Machine
learning was not used to develop this Risk index (Schwartz et al., 2022). They used electronic
health record data that included ICD-9 and ICD-10 codes to classify Type 1. The team used a
70/30 split for training and validation as was done for the analysis described here.

Most of the studies in literature for machine learning and Type 1 diabetes focused on glycemic
management, carbohydrate counting using a mobile application, infection detection, using
momentary assessment for increasing self-management among pediatric patients, pediatric
diabetic retinopathy, real time hypoglycemia prediction and detecting intentional insulin
omission for weight loss among girls with type 1. There were no articles using a LASSO method
for variable selection on DKA for a pediatric population.

An important role of variable selection and prediction models is to inform patients and families
of the potential for an event that can be prevented (Steyerberg, 2009). It is generally
considered that DKA is a preventable outcome. The advent of a risk score or marker to alert the
care team of a change in mode of education methods, family support, diabetes supplies
support or otherwise could prevent some of these instances of DKA. There are many prediction
models being used in present day clinical practice. These include the Framingham Risk Score,
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Ottawa Ankle Rules, EuroScore, Nottingham Prognostic Index and the Simplified Acute
Physiology Score (Steyerberg, 2009).

METHODS AND PROCEDURES
Study Population
The data used in this study comes from the T1D Exchange(T1D Exchange – T1D Exchange, n.d.).
The T1D Exchange began as a non-profit that focused on improving care and outcomes for
those living with Type 1 diabetes. They maintain a longitudinal dataset of patient information
from July 2007 to April 2018 called the T1D Registry. Participation in the dataset is voluntary
across 83 academic sites across the United States. The database includes 34,013 participants.
All patients that attend any of the Registry clinic sites are eligible to be entered in the Registry.
For patients under 18 years of age, a parent or guardian provided consent for medical
information release at regular office visits by both medical record extraction and by completing
optional questionnaires. No tests or procedures were required to be part of the T1D Registry.
The data is deidentified and publicly available. Permission to use the T1D Registry has been
given through the Georgia State University Internal Review Board and is attached in the
appendices.

The T1D Exchange Registry dataset contains values for five different possible study visits. These
visits include Annual, Enrollment 1, Enrollment 2, Year 1 and Year 5. This analysis looked at Year
17

1 data. As DKA is common at diagnosis and the data collected is retrospective, we chose to use
Year 1 data for this study. The response variable was the variable Pt_DKAFg where the value is
1 for the presence of a DKA diagnosis in the previous 3 months before a visit. For this dataset,
we only know if a patient was given a diagnosis of DKA within the 3 months preceding the study
visit for the T1D Exchange.

Outcome and Predictor Variables
The original dataset contains values from 140,461 observations. As it is common to be
diagnosed with DKA at the time of diagnosis, we limited the observations that were labeled
“Year 1” and those with age less than 26. Literature states that HbA1c levels remain stable
through age 26. This ensured that we could maximize the number of observations in the
analysis. This reduced the number of observations in the dataset to 13,644. The original dataset
contained 97 variables or features that were candidates for the model selection. Some variables
were removed logically as this study aims to predict DKA for patients under the age of 26.
Removing these variables reduced some of the missingness seen in the original dataset, even
though it is generally discouraged to remove variables when doing model selection using
machine learning.

There were multiple options for insurance in the dataset as well. Since it is possible to have
more than one type of insurance, we created a new variable which aggregated the insurance
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type. Doing this allowed us to look at the presence of insurance as an effect for DKA rather than
the specific type of insurance.

Summary statistics (mean or median) for continuous variables and percentages and frequency
for categorical variables were computed for the baseline characteristics. The primary outcome
variable was having a diagnosis of DKA in the three months prior to the appointment. The nonmodifiable risk factors chosen from the variable selection are age, diabetes duration in years,
months from consent date to date of HbA1c measurement, height and months from exam date.
These were assessed from clinic study questionnaires and clinic data.

The modifiable risk factors chosen from the variable selection are the number of blood sugar
checks per day as reported by the patient, BMI, the albumin creatinine ratio, HbA1c, lipid values
(HDL, LDL, total cholesterol, triglycerides), weight in kilograms, systolic and diastolic blood
pressure, BUN levels and having at least one severe hypoglycemic event in the past three
months. These were also assessed from the clinic data and study questionnaires.

Method
Analysis was performed using SAS Studio. The HPGENSELECT procedure was used with
Selection=LASSO. The HPGENSELECT procedure fits and builds generalized linear models and is
designed for predictive modeling. It is considered a high-performance procedure. The LASSO
19

method can produce sparser and more interpretable models than some of the other model
selection methods such as forward, backward and stepwise (Rodriguez, n.d.).

The HPGENSELECT procedure does not have graphics options, so PROC LOGISTIC was used with
the variables chosen in the PROC HPGENSELECT procedure to assess the goodness of fit and
graphics. Additionally, a /missing statement was added to allow the procedure to run and use
the variables that were available. AUC and ROC values were used for assessing the predictive
quality and goodness of fit for the resulting logistic regression.

Group lasso procedures allow for variables within a group (such as categorical predictors) to be
removed. It is important to note that we did not allow for split variables. All the levels of the
variable were chosen or none of them were chosen (Schreiber-Gregory et al., n.d.).

Each learning algorithm contains a loss function, an optimization criterion based on the loss
function and an optimization routine that leverages training data to find a solution to the
optimization criteria. Underfitting the model does not allow the model to predict well, or it has
a high bias. Overfitting predicts well from the training but poorly for the test set. This can also
be called high variance. In some cases, the “event” being modeled is relatively uncommon. This
can sometimes lead to overfitting of a model. An overfit model underestimates the probability
of an event in low-risk patients and overestimates it in high-risk patients (Pavlou et al., 2015).
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To help alleviate these concerns, we can regularize or penalize the model to build a simpler or
less complex model. This type of regularization for variable selection is considered an
embedded method as described in the literature review above.

To regularize a model, a penalty term is added to the objective function whose value is higher
when the model is more complex. One type of regularization is called L1 or Least Absolute
Shrinkage and Selection Operator (LASSO.) LASSO regularizes the L1 norm of the vector of
regression coefficients, i.e., the sum of the absolute values of coefficients. Restricting the L1
norm will shrink some of the coefficients to zero and hence remove the corresponding
predictors from the model, which will enhance prediction accuracy (Pavlou et al., 2015).

Specifically, for the logistic regression on K predictors with LASSO regularization, the
parameters are estimated by minimizing the following objective function
-2logL + 𝜆 ∑"
[!$%]|𝛽! |

(1)

where 𝐿 denotes the likelihood function, 𝛽! , k=1…, K, are the slope coefficients to be
estimated, and 𝜆 > 0 is the regularization parameter. We call (1) the penalized likelihood. The
penalty term 𝜆 ∑![!$%]|𝛽! | controls the sparsity of the model. With this penalty term, some
coefficients or 𝛽 values are shrunk to zero. When 𝜆 is equal to 0, the penalty is 0 so minimizing
(1) is equivalent to maximizing the likelihood to estimate parameters. The optimal
regularization parameter is unknown and can be selected by cross-validation procedure or
other criteria such as AIC, BIC. To do this, a dataset is divided into three parts; a training set, a
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validation set and a testing set. In cases where there are relatively few events that are being
used, it is most optimal to use 70% for the training/validation and 30% for the test set rather
than using a 50/50% approach. We use the former ratio for this analysis. Then a model is
employed using the optimal regularization parameter. In the HPGENSELECT procedure, a
partition statement is utilized to do cross-validation.

RESULTS
The following variables resulted from the LASSO variable selection method used in this analysis.
The response variable is the presence of DKA in the previous three months. The maximum
regularization parameter in the model was given as 0.90329 and the chosen regularization
parameter for the model was 0.010404. At each step of variable selection, the lambda is shown
in selection details starting with a lambda of 1 at Step 0 and ending with a lambda of 0.0115 at
Step 20 as seen in Table 2.
Variables included in the final model include age, albumin creatinine ratio (a measure of total
amount of protein in blood), the average number of blood sugar tests per day, diastolic blood
pressure, systolic blood pressure, body mass index (BMI), a blood urea nitrogen test (BUN)
score that is a measure of urea nitrogen in the blood as a measure of kidney waste product,
duration of diabetes in years, HbA1c, high density lipoprotein (HDL), height in centimeters, low
density lipoprotein (LDL), having one severe hypoglycemic event in the three months prior to
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the appointment, weight in kilograms, total cholesterol and triglyceride levels. Effects can be
found in Table 3 at the end of the document.

Most of the effects chosen in the model have known associations to DKA including HbA1c
values, BMI and age. This analysis is unique in that it offers both demographic as well as
biological biomarkers for every patient. The novel biomarkers included in the model are the
albumin/creatinine ratio, diastolic and systolic blood pressure, BUN, HbA1c, HDL, LDL, total
cholesterol, and triglyceride values. Unfortunately, these are not markers that are collected at
every normal 3-month endocrinology checkup, so their inclusion in a model would only be
helpful when they were available. HbA1c, systolic and diastolic blood pressure are collected at
every 3-month endocrinology visit. The American Diabetes Association recommends screening
for dyslipidemia at diagnosis and every 3 years if found abnormal (American Diabetes
Association Professional Practice Committee, 2021). More research is needed on whether these
biomarkers for DKA are seen using prospective data rather than retrospective data for DKA
models.

The given ROC value or Area under the curve (Figure 1) for the fitted model found is 0.7105.
The greater the number for the ROC, the better the prediction. See Figure 1. Additionally, the
model shows a high value for the Hosmer Goodness of Fit test (p-value is 0.7092). This test A
low p-value for this test would indicate that there is no evidence that the model lacks fit with
the data. As the model p-value is not low, we can conclude that the model fits the data
accordingly.
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Many of the variables found from the LASSO regression and included in the model have known
relationships both to each other and to DKA. Several of the variables had odds ratios over 1,
indicating that the odds of DKA, holding all the other variables constant, was greater than not
having DKA. There were three variables that had odds ratios that had p-values less than 0.05
and are considered statistically significant. The value for diastolic blood pressure had an odds
ratio of 1.045 (p-value=0.0302). The odds ratio for HbA1c is 1.368 (p-value=0.0007). Finally, the
odds ratio for the variable indicating a severe hypoglycemic event is 0.239 (p-value=0.0003). As
this odds ratio is less than one, rather than a risk factor for DKA, this indicates that it is a
protective factor.

DISCUSSION
Interpretation of Findings
HbA1c and diastolic blood pressure were found to be significant in this analysis, in particular
the finding of HbA1c. Gosmanov, et al. found that adults in the United States with an HbA1c
above 9.0% had a 12-fold higher incidence of DKA (Gosmanov et al., 2021). Additionally,
Pettus, et al. found that for pediatric patients, age and HbA1c were found to have similar
results and that DKA instances increased with increased levels of HbA1c (Pettus et al., 2019).
The odds ratio found with this analysis was 1.368 (p-value=0.007) for HbA1c. The Schwartz, et
al. study also found HbA1c to be significant in their variable selection method. Fralick, et al.
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found that baseline HbA1c was a strong predictor for DKA. Here LASSO regression was used for
variable selection as well even though the population looked at Type 2 diabetes among adults
(Fralick et al., 2021). Finally, it has been said that HbA1c is a very common predictor for DKA
because it is one of the few biomarkers that is reliably available compared to many other
markers, both demographic and biometric (Kavakiotis et al., 2017). As HbA1c is a requirement
to receive continued insulin prescription refills, it is logical that it is reliably available. Pairing the
availability with its definition it makes sense that HbA1c is often found to be a predictor for
DKA.

The Abaker, et al. study found five variables in their variable selection method. None of these
were the same as those found in our model. The variables found include age, infection years,
BMI, sugar, symptom days with a response variable of DKA occurrence. The dataset used in this
analysis consisted of only 937 cases with 27 possible selection variables (Abaker & Saeed,
2020). A small dataset could be a reason for the difference in variables chosen than those found
in our analysis.

The Lin, et al. study examined several different machine learning methods for variable
selection. This study found systolic blood pressure as a predictor in one of the five methods that
were examined. Interestingly, three of the five methods picked HbA1c as the top predictor for
DKA. The Fan, et al. study included both HbA1c in their list of variables chosen using LASSO
regression for variable selection. Unfortunately, the outcome variable for this analysis was
acute kidney failure for those with DKA.
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Study Strengths and Limitations
When using machine learning, a large amount of data is needed since it will be divided into a
test set, a training set and a validation set. Our response variable was rare, so the need was
even greater to have a large number to start in the overall dataset. The dataset contained over
13,000 patients for use in this analysis. The T1D Exchange dataset also allowed us to have
biomarkers as well as demographic data. Additionally, the care given at academic diabetes
centers might ensure fidelity of the study materials.

Most of the publicly available government datasets such as National Health and Nutrition
Examination Survey (NHANES), Kids’ Inpatient Database (KID) and National Inpatient Sample
(NIS) simply list “any diagnosis of diabetes” as a variable. A diagnosis of diabetes for these
datasets usually means “Has a doctor ever told you have diabetes?” or having a biomarker such
as HbA1c level that is higher than 6.5%. While persons with Type 2 diabetes can and do develop
DKA over the course of their disease, the research question we were looking for included Type
1 diabetes only. The T1D Exchange Registry offered a sample of a population with Type 1 that
was easily identifiable and available.

There are some limitations of the use of this dataset. First, as the study sites are large research
medical sites with academic centers associated with them, the patient populations that utilize
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these sites may have some underlying differences from patients who get their care from
somewhere different than an annexed diabetes center. This may play a role in whether this is
generalizable to the pediatric population with Type 1 diabetes. Finally, the dataset comes from
83 study sites across the country, but there was not a location or clinic site variable in the
dataset available to the public. If academic center data was available, it would have been
possible to do a nested or multi-level model and use that data.

Additionally, while there are multiple methods of imputation used in analysis, it is important to
note the variables that have missingness and assess why they are so. Unfortunately, in the
initial stages of analysis, every record in the dataset contained some missing data. This is likely
due to the nature of the Registry. It is voluntary and there are only 5 maximum entries per
participant. At each of five possible visits, participants provided information to the researcher.
The visit options were Annual, Enrollment 1, Enrollment 2, Year 1 and Year 5. This analysis
looked at Year 1 data. There were 3 variables that did not have any entries for the population
we were interested in. These included a value for TSH, GFR and a value for the total number of
units of insulin used. These values were likely not collected for pediatric patients. After their
removal, we added a /missing statement in SAS that allowed the model to run with the
variables that were in the dataset. We did not impute any missing data in this analysis.
Imputing data was not logical as we were looking for novel unknown variables to be placed in
the model.
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Some of the biomarkers included in the study can be understood to provide insight into both
general health, but also cardiac and endocrine system health such as systolic and diastolic
blood pressure, the albumin/creatinine ratio and urea level in the urine (BUN). Since the values
were recorded after a possible DKA event (both questions were asked or recorded in the
previous 3 months), it is possible that these biomarkers changed because of the DKA diagnosis
rather than them providing predictive ability. These biomarkers can be altered by an
occurrence of DKA.

Lastly, it is possible that there was more than one instance of DKA in the previous 3 months for
the variable chosen. The question asked of the patients was “did you have one or more DKA
events in the 3 months prior to the appointment?” There are only a few effects in our new
model that are collected at every 3-month endocrinology clinic visit or are already known.
These include weight, height, BMI, HbA1c, insurance status, age at diabetes diagnosis, diabetes
duration and patient education level.

Future Study
Considering these limitations, future research could benefit from the use of electronic health
records to have more robust and complete data for variable selection and modeling. As most
large health systems have electronic healthcare databases of patient clinical and demographic
data, doing an analysis using one of those would be an appropriate next step.
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Using a large Electronic Health Record (EHR) dataset, rather than a voluntary retrospective
dataset might provide some insights into the variables that can predict future incidences of
DKA.

Using a multilevel model using the T1D exchange dataset would enable analysis for within
patient DKA and to detect biometric changes over time. Replicating this data on the Year 5 data
as well as the Enrollment data might provide some important data for the diabetes community.
Finally, if location or a time element could be added to this T1D exchange dataset, it would be
possible to do different and more complex analysis relating to DKA among pediatric patients.

Conclusions

Using the T1D Exchange dataset and a LASSO regression for variable selection, we selected a
model with 16 variables. Six of these variables were deemed to be non-modifiable. Ten of the
variables can be considered modifiable. Two of the variables had statistically significant odds
ratios for risk factors for DKA. These included HbA1c and diastolic blood pressure. The model
chosen showed that it offered appropriate goodness of fit for assessing and targeting
interventions to reduce the modifiable risk factors found in this analysis.

The problem of finding modifiable risk factors for pediatric patients continues to be challenging,
even if it is vitally important. The data in this study were both collected retrospectively and
voluntarily, and their use for a predictive model should be used with caution. Machine learning
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techniques offer the potential to identify novel risk factors for DKA among pediatric patients if
EHR are used and the dataset is large enough.

Finding modifiable risk factors for DKA could potentially lower the overall personal and societal
cost of DKA to pediatric and young adult patients and their families. Reducing the incidence of
DKA for pediatric type 1 patients is in the best interest of patients, their caregivers, and the
health system. This analysis additionally contributes to the body of work regarding DKA
prevention among pediatric patients with Type 1 diabetes.
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Figures and Tables
Table 1: Baseline Patient Characteristics

Baseline Characteristics
Age (years)
Albumin Creatinine Ratio
Average number of Blood sugar checks per day
Systolic Blood Pressure
Diastolic Blood Pressure
BMI
BUN
Duration of Diabetes (years)
HbA1c (%)
HbA1c Imputed date (months)
HDL
Height (Cm)
LDL
Weight (Kg)
Total Cholesterol
Triglycerides
Hypoglycemic event in past 3 months (%)

Mean (or %), SD
13.9 (5.0)
20.1 (76)
5.7 (2.5)
67.0 (8.6)
113.0 (12.5)
21.9 (5.1)
13.7 (5.6)
6.2 (4.6)
8.5 (1.6)
14.5 (4.7)
58.2 (14.8)
155.0 (20.0)
91.7 (28.0)
55.5 (21.4)
166.0 (32.0)
99.0 (75.0)
7.2
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Table 2: Progression of Variable Selection as Lambda Changes
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Table 3: Odds Ratio estimates of the effects chosen in the Lasso regression

Effect

Point Estimate
for Odds Ratio

95% Wald
Confidence Limits

Age

0.858

0.746

0.985

Albumin Creatinine Ratio

1.002

0.998

1.006

Number of Blood Glucose Tests per day reported by the patient

0.995

0.847

1.169

Diastolic Blood Pressure

1.045

1.004

1.008

Systolic Blood Pressure

1.014

0.980

1.050

BUN (Blood Urea Nitrogen Test)

1.032

0.960

1.109

Diabetes Duration in Years

0.997

0.918

1.083

Body mass index (BMI)

1.411

0.946

2.103

Time in Months since Exam date

1.030

0.959

1.106

HbA1c

1.368

1.141

1.641

HDL

1.016

0.976

1.058

Height (in cm)

1.111

0.992

1.249

LDL

1.022

0.988

1.057

Severe Hypoglycemic Event in the previous three months

0.239

0.111

0.517

Weight in Kg

0.877

0.753

1.012

Total Cholesterol

0.978

0.946

1.102

Triglyceride level

1.001

0.993

1.008
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Table 4 : Modifiable and Non-Modifiable Variables
Non-Modifiable

Modifiable

Age

Number of Blood Glucose checks reported by
the patient

Diabetes duration in years

BMI

Months from consent date to date of HbA1c
measurement

Albumin Creatinine ratio

Height

HbA1c

Months from exam date

HDL/LDL/Total Cholesterol/Triglycerides
Weight
Systolic Blood Pressure
Diastolic Blood Pressure

BUN
At least one hypoglycemic event in the past 3
months
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Figure 1: ROC Curve for model chosen.
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